Study of the NR4A family gene expression in patients with multiple sclerosis treated with Fingolimod
Sign Up to like & getrecommendations! Published in 2019 at "European Journal of Neurology"
DOI: 10.1111/ene.13875
Abstract: Fingolimod is a drug approved for treatment of relapsing‐remitting multiple sclerosis (RRMS) that exerts its effects via sequestering lymphocytes within the lymph nodes. The drug, acting on the sphingosine‐1‐phosphate pathway, is involved in a plethora… read more here.
Keywords: sclerosis; family gene; nr4a family; gene expression ... See more keywords